Page 35 - FINAL PROGRAMME 2017

PRECONGRESS COURSE 09
Sunday, 2 July 2017 I Room G
Transgenderism and reproduction: State of the art in fertility options for transgender and people with sex reassignment
Organised by Special Interest Groups Safety and Quality
in ART, Psychology and Counselling, Ethics and Law
and Global and socio-cultural aspects in ART
COURSE COORDINATORS
Guido Pennings (Belgium), So a Gameiro (Portugal), Arianna D’Angelo (United Kingdom), Françoise Shen eld (United Kingdom)
COURSE DESCRIPTION
Transgender people who want to transition to their desired gender have to undergo hormonal and surgical treatments, which leads to irreversible loss of their reproductive potential. It is thus important to discuss fertility preservation option with these patients and to present and counsel the patients concerning the possibilities enabling them to ful l a future child wish. This course will provide insight on what these possibilities and option for fertility preservation are. It will also provide input on counselling of this speci c patient cohort and discuss the ethics concerning certain controversial topics.
The aim of this course is to create awareness around transgenderism and fertility, provide knowledge on treatments and counselling from experiences in centres of excellence on transgender care, present a transgenders’ perspective on fertility and deliver guidance for qualitative and safe treatment options in ART centres.
TARGET AUDIENCE
Embryologists, Andrologists, Clinicians, Specialty Trainees, Psychologists, Nurses, Midwifes, Quality Managers
EDUCATIONAL NEEDS AND EXPECTED OUTCOMES
At the end of this course the audience should have a better understanding of the above outcomes.
• To review different approaches in clinical treatments and options and their results.
• To investigate the level of evidence related by exploring guidelines available in current practice.
• To promote training and education.
• To assess how doctors/ nurses apply and manage the treatment options.
• To learn about different perspectives.
• To assess quality and safety of ART treatments
Chairman: Arianna D’Angelo (United Kingdom) and Zdravka Veleva (Finland)
09:00 - 09:30 09:30 - 09:45 09:45 - 10:15 10:15 - 10:30 10:30 - 11:00
Gender dysphoria and fertility – Katarina Link (Sweden)
Discussion
Endocrinological burden on fertility during cross hormonal therapy – Petra De Sutter (Belgium) Discussion
Coffee break
FINAL PROGRAMME I GENEVA, SWITZERLAND – 2 TO 5 JULY 2017 35
PRECONGRESS COURSES